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A Combinatorial Algorithm for 
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Synthetic biology has boomed since the early 2000s when it started being shown that it was possible 
to efficiently synthetize compounds of interest in a much more rapid and effective way by using other 
organisms than those naturally producing them. However, to thus engineer a single organism, often a 
microbe, to optimise one or a collection of metabolic tasks may lead to difficulties when attempting to 
obtain a production system that is efficient, or to avoid toxic effects for the recruited microorganism. 
The idea of using instead a microbial consortium has thus started being developed in the last decade. 
This was motivated by the fact that such consortia may perform more complicated functions than could 
single populations and be more robust to environmental fluctuations. Success is however not always 
guaranteed. In particular, establishing which consortium is best for the production of a given compound 
or set thereof remains a great challenge. This is the problem we address in this paper. We thus introduce 
an initial model and a method that enable to propose a consortium to synthetically produce compounds 
that are either exogenous to it, or are endogenous but where interaction among the species in the 
consortium could improve the production line.
Synthetic biology has been defined by the European Commission as “the application of science, technology, and 
engineering to facilitate and accelerate the design, manufacture, and/or modification of genetic materials in liv-
ing organisms to alter living or nonliving materials”. It is a field that has boomed since the early 2000s when in 
particular Jay Keasling showed that it was possible to efficiently synthetise a compound–artemisinic acid–which 
after a few more tricks then leads to an effective anti-malaria drug, artemisinin1. Such chemical compounds were 
naturally produced only in the plant Artemisia annua, a type of wormwood, in quantities too small to enable a 
cheap production of the drug. To address this problem, a living organism, Saccharomyces cerevisiae, was used for 
such rapid, and therefore much more effective synthetic production. Since the work by J. Keasling, many other 
species, in particular bacteria, have also been manipulated with a similar objective of more efficiently producing 
some compounds of interest for health, environmental or industrial purposes.
However, engineering a single microorganism to optimise one or a collection of metabolic tasks may often 
lead to considerable difficulties in terms either of getting an efficient production system, or of avoiding toxic 
effects for the recruited microorganism2. The idea of using a microbial consortium has thus started being devel-
oped in the last decade2–5. This can indeed allow to perform more complex tasks, for example by splitting the 
work between the members of the consortium, by alleviating an inhibition due to toxic compounds as we show 
later, or even by obtaining a culture more resistant to environmental changes. Microorganisms may thus be more 
efficient synthetic factory workers as a group than as individual species, as already shown for problems related to 
remediation or energy6,7. However, difficulties may arise, limiting or preventing the success of such community 
approaches8,9. Finally, selecting the members of the consortium to produce one or several compounds remains a 
challenge2.
In this paper, two types of consortia are studied. The first is a synthetic consortium of strains carrying genetic 
and/or regulatory modifications. This follows the same spirit as in the work of Jay Keasling for the production of 
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artemisinic acid. In our case, the goal is the synthetic production of two bioactive compounds with antibacterial 
properties: penicillin and cephalosporin C. Four microorganisms were considered for such production. Notice 
that already an important question is whether the best option is to use all four in the consortium, or instead only a 
subset thereof, and of course, which subset is then most efficient. In this first case study, the compounds of interest 
are exogenous to the consortium.
In the second case study addressed, the two microorganisms form an artificial consortium in the sense that the 
species involved in it do not naturally interact, and both organisms are able to endogenously produce the target 
compounds. One of these is 1,3-propanediol (PDO), a building block of polymers. Associating microorganisms 
in a consortium can lead to a better yield of production as already demonstrated by Bizukojc et al.10. This however 
is not the only consortium that may be considered.
In both cases, it is necessary to infer the transfer of metabolites from one organism to another and, if the 
compounds are exogenous to the selected organisms, which reactions need to be inserted in the consortium. For 
such problems, computer models are crucial in providing hints on how to best divide a given metabolic produc-
tion line among different organisms that are then made to interact with one another. Various methods exist that 
enable to better understand the metabolic capabilities and the interactions observed in natural communities11,12, 
but they do not take into consideration the production of specific products from selected substrates. This issue 
was addressed more recently by Eng and Borenstein13 while minimising the number of species in the commu-
nity. In this paper, we present a different model to solve both biological cases considered above that attempts to 
strike a balance between the exchanges that would be required among the species involved in the consortium 
and the genetic modifications that would be needed. To this purpose, we use a weighted network, thus assigning 
a priority of use to some reactions over others. This enables on one hand to either favour or on the contrary, dis-
favour a transport reaction, and on the other hand to reflect the difficulties associated with inserting exogenous 
genes.
Indeed, the problem of obtaining an optimal consortium includes at least the following two parallel objectives: 
one is to have a small number of reactions exogenous to the consortium that need to be added to it, the second 
is to have a small number of compounds that need to be transported across different species of the consortium. 
Both are indeed costly and should thus be avoided whenever possible. Other aspects would also need to be taken 
into consideration, such as the efficiency of the consortium in terms of both survival and growth of each species 
composing it, as well as of production of the compounds of interest. In this paper, we address only the first two 
objectives of minimising the number of insertions of exogenous reactions and of transitions. Our approach is 
purely combinatorial and topological. We do not take into account stoichiometry for the moment. This approach 
however represents a first step that, as we show, leads already to a hard problem. We start by some preliminaries 
that present the basic notations and definitions used, the model adopted, and a formal description of the problem 
addressed. Following the idea initially introduced by Fellows et al.14,15, we then explore how different parameters 
of the problem and combinations thereof influence its complexity. We propose an initial algorithm, MultiPus, for 
addressing this problem. However, because of an increasing running time on genome-scale metabolic models 
(GEMs), MultiPus is also available using an Answer Set Programming (ASP) solver16 which is more efficient in 
general. Finally, we present the two production cases explored with MultiPus.
Preliminaries
Notations and basic definitions. We work with a directed hypergraph representation of a metabolic net-
work, using genome-scale metabolic models (GEMs). Let then  be a directed hypergraph defined on a set of 
vertices, denoted by V, that corresponds to the compounds, and a set of directed hyperedges, that is of hyperarcs, 
denoted by A, that corresponds to the reactions. Given a hyperarc a, we denote by src(a) and tgt(a) the sets of 
source and target vertices of a, respectively, that is the set of substrates and of products. In the problem described 
below, the main issue comes from the hyperarcs with multiple source vertices. The possible multiplicity of the 
target vertices of a hyperarc does not affect the complexity of the problem. Moreover, we can, without loss of 
information, decompose such hyperarcs into ones that each have the same set of source vertices but only one of 
the target vertices of the original hyperarc (as explained in the Supplementary Material). We therefore make this 
assumption from now on.
For a subset of hyperarcs A′ ⊆ A, V(A′) denotes the set of vertices that are involved in at least one hyperarc 
of A′, that is the set of compounds that participate in at least one of the reactions represented by A′. By abuse of 
notation, given a set of hyperarcs A′, we often refer to the hypergraph (V(A′), A′) simply as A′.
Since a reaction needs all its substrates to be activated, we consider that the multiple source vertices of a 
hyperarc correspond to a multiplicity of tentacles (often used for grasping), each associated to one substrate. A 
hyperarc is therefore like an octopus, only with a number of tentacles that may be different from eight. The greater 
the number of tentacles, the more tentacular is the hyperarc considered to be.
We formally introduce the notion of a tentacular hyperarc as follows.
Definition 1. A hyperarc a is called tentacular with number of tentacles, or spreadness for short, b if b = |src(a)| > 1.
Finally, we define the notion of the total number of tentacles, total spreadness for short, of a directed hypergraph.
Definition 2. Given a directed hypergraph H(V,A), its total spreadness is the sum of the number of sources of the 
tentacular hyperacs in .
For the sake of simplicity, we will use the term arc to refer to non tentacular hyperarcs. It will later become 
clear why we need to consider the total spreadness of the input.
Model adopted. We recall that the problem we want to address concerns the production by a consortium 
of organisms, microbes for instance, of a set of compounds denoted by T. The compounds of interest may not 
www.nature.com/scientificreports/
3Scientific RepoRts | 6:29182 | DOI: 10.1038/srep29182
be produced naturally by the members of the consortium; they are instead produced by other organisms (in the 
example given in the introduction, this is a plant). We denote these two sets by, respectively, Ow (the workers to be 
used to synthetically produce the compounds in X) and Oo (those other organisms, used as reference, where the 
compounds in T are naturally produced). As indicated, we may have |Oo| = 0 meaning here that the workers are 
naturally able to produce the compounds.
Let N1, …, Nk be the genome-scale metabolic models (GEMs) for the organisms in Ow, and let V1, …, Vk 
respectively correspond to the sets of vertices in these networks. Actually, this is a superset of the consortium that 
may really be required for the production of T and that will be a solution of the problem as defined below. The 
hyperarcs in Ni have weight wworker, independently of i.
Typically wworker will be set equal to zero, or to a value that is close to zero for reasons that will be explained 
later, in the Application part. The set of hyperarcs in the metabolic models for Oo is denoted by Ao.
The directed hypergraph  = V A( , ) that is the input to our problem is constructed in the following way.
First, we perform the disjoint union of the networks N1, …, Nk. Let  be such that  = …⊍ ⊍N N k1 . Thus 
for now = …⊍ ⊍V V V k1  and = …⊍ ⊍A A Ak1 . Then, for each network Ni, and for each hyperarc a ∈ Ao that 
corresponds to a reaction not already in Ni, we create a copy of it in Ni, and thus in . We add the hyperarc a 
labelled as ai to Ai. We further add to Vi, and thus to V any vertex corresponding to a compound not already in Ni 
if such exists. The added hyperarc has weight wother. Typically, wother > wworker: introducing a reaction in the metab-
olism of an organism that does not contain the corresponding enzyme(s) is indeed costly. Finally, for each pair of 
vertices vi ∈ Vi and vj ∈ Vj with i, j ≤ k and i ≠ j such that the corresponding compound is the same, we create a 
hyperarc that has vi for single source and vj for single target (it therefore is an arc) and has weight wtransition. 
Typically, we will have that wtransition > wworker: making a transition from one organism of the synthetic consortium 
to another, which implies transporting a compound, is also costly.
It is worth calling attention to the fact that we are considering here that adding a reaction from Oo to an organ-
ism from the consortium Ow (when such operation is required) implies a cost that does not depend on the reac-
tion. Similarly, we are considering that any transition from one organism in Ow to another is equally costly. These 
assumptions may however be refined by making such costs, and thus the weights of the added hyperarcs (ten-
tacular hyperarcs or arcs) depend on the reaction or on the transition (see later for a further discussion on this).
Problem definition. We first introduce the notion of a directed rooted hypergraph.
Definition 3. A directed hypergraph ′ = ′ ′V A( , ) is rooted at S ⊆ V′ if there exists an ordering of its hyperarcs 
(a1, …, am) such that for all i ≤ m, src(ai) ⊆ S ∪  tgt({a1, …, ai−1}).
The problem that we address in this paper is defined as follows:
Directed Steiner Hypertree (DSH) problem
Input: A weighted directed hypergraph = V A w( , , )  where w is the set of weights associated to the hyperarcs 
in A, a set of sources S and a set of targets T.
Output: A directed hypergraph ′ = ′ ′V A( , )  rooted at S, with V′ ⊆ V and A′ ⊆ A, of minimum weight such that 
T ⊆ tgt(A′).
Notice that the term Directed Steiner Hypertree abuses language in the sense that there may be more than one 
root. In the case of digraphs, it would correspond to a set of trees, hence to a forest.
Relation to known problems. If the directed hypergraph is a digraph, then it is a minimal directed hypergraph 
rooted at a node s if and only if it is an arborescence rooted at s (i.e. a directed tree with an orientation from the 
root s to the leaves). If there is more than one source, then it is a set of arborescences. In the case of digraphs, the 
DSH problem coincides with the well-studied Directed Steiner Tree (DST) problem defined as follows:
Directed Steiner Tree (DST) problem
Input: A weighted directed graph G = (V, A), a source s and a set of targets T.
Output: A subset A′ of A of minimum weight such that T ⊆ closureA′(s).
The closure operation is defined as follows: Given a directed hypergraph = V A( , ) , a set of vertices X such that 
X ⊆ V and a set of hyperarcs A′ such that A′ ⊆ A, closureA′(X) is the smallest set C ⊆ V such that X ⊆ C and for 
each a ∈ A′, if src(a) ⊆ C, then tgt(a) ⊆ C.
Intuitively, closureA′(X) is the set of vertices that can be reached from X following the hyperarcs in A′. In the 
context of metabolic networks, it is the set of compounds that the reactions from A′ can produce using only the 
compounds of X as sources.
Complexity of the problem. We start by investigating the complexity of the problem. We first observe that 
the Directed Steiner Tree problem is NP-hard17. The Directed Steiner Hypertree problem is also NP-hard, even on 
graphs, indicating that it is highly unlikely that there exists an efficient (polynomial time) delay algorithm for its 
solution. However, if the number of targets is considered a constant, then there exists an algorithm with polyno-
mial running time. DST is said to be Fixed Parameter Tractable (FPT) with the number of targets as parameter. 
This implies that DSH also admits an FPT algorithm for a constant number of targets in the case where the input 
is a directed graph.
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In the general setting however, Proposition 1 indicates that the problem is doomed to be intractable 
when using only parameters related to the solution size. The proofs of the propositions are available in the 
Supplementary Material and in the Supplementary Figures S1 and S2.
Proposition 1. The problem is W[1]-hard when parameterised by any combination of: |A′|, weight(A′), |T|, |S|, total 
number of tentacles of the hyperarcs in A′.
Part of the difficulty indeed comes from the choice of tentacular hyperarcs that must belong to the solution. 
However, taking into account only the number of tentacular hyperarcs in the instance is not sufficient to obtain 
tractability.
Proposition 2. The problem is NP-hard even when |T| = 1 and A contains only one tentacular hyperarc.
Overall, the problem remains intractable when either of these constraints applies to the input: there are few 
targets, or the total number of tentacles of the hyperarcs is bounded. However, there remains the stronger case 
when both quantities (number of targets and total number of tentacles of the hyperarcs) are bounded. We present 
a fixed-parameter tractable algorithm for this case in the next section.
Algorithm
We now present our main algorithm that exactly solves the Directed Steiner Hypertree problem provided that 
the number of targets and the total number of tentacles of the hyperarcs remain small. Intuitively speaking, the 
algorithm identifies the best combinations of tentacular hyperarcs by trying all those in parallel, and for each 
such combination, it outputs the solutions (if any exists) having minimum weight. More precisely the algorithm 
enumerates all possible combinations of tentacular hyperarcs that will be used in a solution, where a combina-
tion is a subset of the tentacular hyperarcs ordered according to the topological order of the solution (with k 
tentacular hyperarcs, there are 2kk! such combinations to consider). For each combination, it remains to com-
pute the optimal way of linking these tentacular hyperarcs with regular arcs. This problem is solved by extend-
ing the FPT algorithm for the Directed Steiner Tree problem which requires the number of targets as a 
parameter. In our case, we need the number of targets plus the total number of tentacles of a solution. For a 
given directed weighted hypergraph  = V A( , ), we denote by G ( ) the graph obtained from  by removing 
all tentacular hyperarcs. Let ST(x, X) be the best directed Steiner tree of G ( )  rooted in x that has X as set 
of leaves.
Given an ordered subset M := (a1, …, ak) of the tentacular hyperacs of , we describe a dynamic program-
ming algorithm to find the best Directed Steiner Hypertree with hyperarc set A′ that uses exactly the tentacular 
hyperarcs of M following their ordering.
The following definitions are illustrated in Fig. 1. Since all tentacular hyperarcs of M must be used, we have 
that, for all i ≤ k, src(ai) ⊆ tgt(A′) ∪ S, and so the set src(M) can be seen as an additional set of targets. We estab-
lish T′ := T ∪ src(M) to be the new set of targets, and for t ∈ T′, we define LayerT(t) := min{i ≤ k: t ∈ src(ai)}. If 
t ∈ T\src(M), we define LayerT(t) as k + 1, and for a subset X ⊆ T′, we define LayerT(X) := min{LayerT(t): t ∈ X}. 
Similarly, since all tentacular hyperarcs of M must be used, intuitively tgt(M) can be seen as an additional set of 
sources. We write S′ := S ∪ tgt(M) and LayerS(s) := min{i ≤ k: s ∈ tgt(ai)} if s ∈ tgt(M)\S, and LayerS(s) := 0 if s ∈ S. 
To respect the ordering of M, the target of a tentacular hyperarc ai ∈ M can be used to “reach” only the sources 
of the tentacular hyperarcs that come after ai in M. For all Y ⊆ T′, we define SY := {s ∈ S′|LayerS(s) < LayerT(Y)}.
Observe that for any minimal Directed Steiner Hypertree A′, the vertices in G(A′) must have in-degree one if 
they are not in S′, and, by minimality, out-degree at least one if they are not in T′.
Given a (directed) forest F, we denote by V(F) and leaves(F) respectively the vertices and the leaves of all the 
trees of F. For any vertex t, we denote by root(F, t) the root of the tree in F containing t when t ∈ V(F) (the root is 
Figure 1. Illustration of the notion of layers: Given M = (a1, a2, a3) (thick tentacular hyperarcs), and a 
solution A′ containing M, G(A′) (dashed arcs) consists of a forest covering all T′, i.e. each vertex in t ∈ T′ is 
part of a tree whose source is in a lower “layer” than t. 
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the farthest vertex we can reach starting from t by following only branches of F), or root(F, t) = t otherwise (t is 
an isolated node).
For a set of targets Y ⊆ T′, we say that a forest F of G ( )  covers Y if leaves(F) ⊆ Y and root(F, t) ∈ St for all 
t ∈ Y.
Lemma 1. For any optimal solution A′ of the Directed Steiner Hypertree problem given S T( , , )  as input, if A′ uses 
exactly the tentacular hyperarcs of an ordered subset M, then G(A′) is a forest covering T′.
Proof. Consider a Directed Steiner Hypertree A′. First notice that by minimality, G(A′) is a forest. Indeed, if some 
vertex x has two incoming arcs in A′, denoted by a and a′, a appearing before a′ in A′, then removing arc a′ yields 
a strictly better solution to the Directed Steiner Hypertree problem. Furthermore, if any x ∉ T′ is a leaf of G(A′), 
with incoming arc a, then x is not the head of any arc nor is it part of T′. In this case, a can be deleted and all leaves 
are in T′.
Consider now any t ∈ T′. Let s = root(F, t). Consider the path from s to t: by minimality, the arcs of the path 
must appear in the same order as in A′ (otherwise some arcs must be deleted), and s must appear in the targets 
of a tentacular hyperarc ordered before any hyperarc of which t is a source (or s ∈ S). This implies that s ∈ St. ◻
Lemma 2. Given an ordered subset of tentacular hyperarcs M and any forest F covering T′, there exists a solution A′ 
of the Directed Steiner Hypertree problem with  S T( , , ) as input, where A′ uses exactly the tentacular hyperarcs of 
M in this order, and such that G(A′) = F.
Proof. We build A′ as follows. We first insert the tentacular hyperarcs (a1, …, ak) of M, in this order. We then insert 
the arcs of F between the tentacular hyperarcs, according to the layer of the root of the tree to which they belong. 
Formally, let D1, …, Dp be the directed trees in F, and s1, …, sp their respective roots. Observe that since all leaves 
are in T′, then each si can be written as root(F, t) for some t ∈ T′, and thus si ∈ S′ and LayerS(si) is well-defined and 
can be computed. For each j, 1 ≤ j < k (respectively, j = 0 or j = k), we insert between aj and aj+1 (resp. before a1 or 
after ak), all arcs of all trees Di such that LayerS(si) = j. Within each tree, the arcs are inserted in topological order. 
There remains to prove that this ordering has the required properties.
We first verify that for any t ∈ T, t is reached by some hyperarc (tentacular or not) of A′. Two cases are possible:
1. If t = root(F, t) (i.e., either t is the root of some tree of F or t ∉ V(F)), then t ∈ tgt(ai) for some ai ∈ M ⊆ A′, 
thus t ∈ tgt(A′).
2. Otherwise, t ∈ tgt(a) for some arc a in F, so a ∈ A′ and t ∈ tgt(A′).
For any vertex x ∈ src(a) with a ∈ A′, we now need to verify that x ∈ S or x is the target of some hyperarc 
selected before a. Three cases apply:
1. If a ∈ F and x is not the root of any tree Di, then it has an incoming arc appearing in A′ before a (since we 
kept the topological order of each tree).
2. If a ∈ F and x is the root of some tree Di, then x = si. If x ∉ S, then LayerS(x) > 0, and x is produced by the 
tentacular hyperarc aLayer x( )S  which appears before a.3. If a is not an arc of F, then it is a tentacular hyperarc, x ∈ T′, and a = aj for some j > LayerT(x). Let 
si = root(F, x), then LayerS(si) + 1 ≤ LayerT(x), and the arc producing x is placed before +aLayer s( ) 1S i , which 
in turn is before (or equal to) the arcs aLayer x( )T  and a = aj.
Overall, we indeed have a Directed Steiner Hypertree for S T( , , )  using M, where, by construction, 
G(A′) = F. ◻
Lemma 3. For any optimal solution A′ of Directed Steiner Hypertree of  S T( , , ), if A′ uses exactly the tentacular 
hyperarcs of an ordered subset of tentacular hyperarcs M in this order, then G(A′) is a forest covering T′ of minimum 
weight.
Proof. By Lemma 1, F = G(A′) is already a forest, and it has a total weight of weight(F) = weight(A′) − weight(M). 
Consider any forest F′ of weight w′ covering T′. By Lemma 2, there exists a solution with weight 
weight(F′) + weight(M), which must be larger than weight(A′), hence w′ ≥ weight(F), i.e. F has minimal weight. ◻
For a set of targets Y ⊆ T′, let SHM(Y) be the minimum weight of a forest F covering Y under the ordering M. 
By Lemma 3, the weight of an optimal solution A′ of the Directed Steiner Hypertree problem given S T( , , )  as 
input is weight(M) + SHM(T′) where M is the ordered set of tentacular hyperarcs used by A′.
Theorem 1. The optimal value of an instance of  S T( , , ) of the Directed Steiner Hypertree problem has value 
SHM(T′) + weight(M) for some ordering M. Furthermore, *SHM can be computed recursively as follows. For any 
Y ⊆ T′,
= ∈ ′ + ′
′⊂
Y s Y s S Y Y YSH ( ) min(min {ST( , ), }, min {SH ( ) SH ( \ )})M Y
Y Y
M M
Proof. Assume first that the optimal forest F covering Y is a tree and let s ∈ SY be its root. Then SHM(Y) = ST(s, Y) 
= min{ST(s, Y), s ∈ SY}.
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Assume now that F has at least two trees. Let Y′ := leaves (F1) where F1 is a tree of F. Notice that since F1 and the 
other trees of F do not intersect, we have weight(F) = weight(F1) + weight(F\F1). Furthermore, F1 is an optimal 
forest covering Y′ and F\F1 is an optimal forest covering Y\Y′ since otherwise, the union of two better solutions 
would lead to a better forest covering Y. We then have that SHM(Y) = SHM(Y′) + SHM(Y\Y′) and 
≥ ′ + ′
′⊂
Y Y Y YSH ( ) min {SH ( ) SH ( \ )})M
Y Y
M M . Finally, assume that there exists Y′ ⊆ Y such that SHM(Y) > SHM(Y′) + 
SHM(Y\Y′) and let F′ (resp. F′′) be an optimal forest covering Y′ (resp. Y\Y′). Then F′ ∪ F′′ would be forest covering 
Y of weight weight(F′ ∪ F′′) ≤ SHM(Y′) + SHM(Y\Y′) < F, contradicting the optimality of F. Thus  YSH ( )M
= ′ + ′
′⊂
Y Y Ymin {SH ( ) SH ( \ )})
Y Y
M M . ◻
Theorem 2. The Directed Steiner hypertree problem is Fixed-Parameter Tractable for the parameters |T| and total 
number of tentacles of the hypergraph.
Proof. The algorithm computes SHM(T′) for each ordered subset M of tentacular hyperarcs. Since the number 
of tentacular hyperarcs is bounded by the total number of tentacles k of the hypergraph, there are at most 2kk! 
ordered subsets of tentacular hyperarcs. For a given M, we now compute SHM(T′) using a dynamic programming 
algorithm induced by the recursion of Theorem 1. We need to store the value of SHM(Y′) for every subset Y′ of T′. 
Since the size of T′ is bounded by k + |T|, we have at most 2k+|T| such subsets. Finally, since for every vertex s and 
every Y′ ⊆ T′, the computation of ST(s, Y′) is FPT in |Y′| ≤ |T′| ≤ k + |T|, the total running time of the algorithm 
is FPT in k + |T′|. ◻
Application
The main objective of microbial consortia engineering is to highlight their capacity to reach enhanced produc-
tivity, stability or metabolic functionality3. More in particular in this paper, we explore the possibility of such 
consortia to produce compounds of interest using low cost substrates (such as, for instance, the waste of other 
industries).
We initially focused attention on the production of two bioactive compounds: penicillin and cephalosporin C, 
useful to the pharmacology industry for their antibiotic properties. For this production, a synthetic consortium 
defined as a system of metabolically engineered microbes which are modified by genetic manipulations and/or 
regulatory processes2 has been tested, using distant species as will be explained in the first example. The goal in 
this case was to take advantage of the different metabolic capabilities of the organisms composing the consortium 
for the de novo synthesis of bioactive metabolites and to show that the model is able to select the Directed Steiner 
Hypertree of least cost to produce one or a set of metabolites of interest.
We then considered the case of an artificial consortium. This corresponds to a system composed of wild-type 
populations that do not naturally interact2. We tested the association of a natural 1,3-propanediol (PDO) pro-
ducer Klebsiella pneumoniae with an acetogenic Archae Methanosarcina mazei. The goal is to obtain a higher yield 
of 1,3-propanediol. Indeed, production of this compound in a pure culture of K. pneumoniae is associated with 
production of acetate. The latter has an inhibiting effect on bacterial growth, and ultimately also on the produc-
tion of PDO. Hence associating K. pneumoniae with a methanogen has been proposed to reduce such effect5,10.
All the genome-scale models (GEMs) used were extracted from Kegg18 using MetExplore19. In both 
examples, cofactors and co-enzymes obtained from a list available in Kegg18 were removed. The networks, con-
structed as explained previously, were filtered using a lossless compression step (see Supplementary Material and 
Supplementary Figures S3 and S4). The resulting networks have a high number of tentacular hyperarcs. In the 
first case, the directed hypergraph contains 10087 arcs and 285 tentacular hyperarcs (that is, arcs with at least 
two substrates). The total number of tentacles of the graph is 575. In the case of improved PDO production, the 
network contains 1606 arcs and 71 tentacular hyperarcs for a total number of tentacles of 142. Because of the 
high number of total spreadness, we used an ASP (Answer Set Programming) solver16 to enumerate the optimal 
solutions, namely the sets of reactions with minimum total weight such that the target compound(s) could be 
produced using only the given substrate(s).
In the absence of any prior knowledge, the weights were set uniformly using as a priori the fact that endoge-
nous reactions should be easier to use than transport ones (no need to export or to uptake compounds) and than 
insertions (since this implies introducing one or several genes and over-expressing them).
Therefore, the following weights were first applied: wworker = 1, wother = 100, wtransition = 100. Notice that the 
weight of the (hyper)arcs that are present in the organisms forming the consortium is not zero, but instead equal 
to a value above zero that remains however small in relation to the weights of an insertion or of a transition. The 
motivation for this is to favour solutions which, while minimising the number of insertion or transition hyperarcs 
that are used, also minimise the number of hyperarcs corresponding to reactions that are internal to the micro-
organisms in the consortium.
In the second application, two sets of transport weights were adopted, one a refinement of the first, as will be 
explained later on.
Antibiotics production. In this first application, a synthetic consortium of three Actinobacteria 
(Streptomyces cattleya, Rhodococcus jostii RAH_1, Rhodococcus erythropolis BG43) and one methanogenic 
Archaea (Methanosarcina barkeri) was tested to determine which microbial consortium could produce a set of 
metabolites of interest. In this case, two well-known beta-lactam antibiotics (penicillin and cephalosporin C) 
were selected. Both active compounds belong to the cephalosporin/penicillin pathway and share several meta-
bolic reactions. They also have a common precursor, namely isopenicillin N, are commonly used for their anti-
bacterial properties and are naturally produced by fungi belonging to the Aspergillus and Cephalosporium species 
www.nature.com/scientificreports/
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(Aspergillus chrysogenum and Cephalosporium acremonium respectively)20. In this case, cellulose was used as 
carbon source. Indeed, life on earth depends on photosynthesis, which results in the production of plant biomass 
having cellulose as major component, and cellulosic materials are particularly attractive in this context because of 
their relatively low cost and plentiful supply21.
Microorganisms were chosen because of the availability of Actinobacteria to produce bioactive compounds 
(representing about 45% of all the microbial bioactive products discovered22). Furthermore, the phylogenetic 
distance between Actinobacteria and Archaea suggests variability in their metabolisms. The presence of reactions 
that are specific to each organism means that there might be a gain in the overall metabolic capabilities from mak-
ing the two bacteria work together. Using a consortium could thus be more efficient to produce one or several of 
the metabolites of interest. In addition, two other organisms (henceforth called reference organisms) were used for 
reaction insertion: Aspergillus nidulans and Streptomyces rapamycinicus. The first is a fungus known to produce 
penicillin while the second possesses reactions in the penicillin/cephalosporin C pathway, and in particular those 
needed to produce cephalosporin C. All the reactions present in the reference organisms were added to the four 
prokaryotes forming the consortium (as described in Model adopted).
Four solutions with a minimum cost of 528 (2 transports, 3 insertions, and 28 endogenous reactions) are 
found. All of them are composed of Streptomyces cattleya and Methanosarcina barkeri showing that topologi-
cally, there is no need to use the other two Actinobacteria to produce both beta-lactam antibiotics. Two of them 
are presented in Fig. 2. The other two use another metabolite transport (i.e. L-2-aminoadipate) and are illus-
trated in the Supplementary Figure S5. In this case, the insertion of the reaction transforming 2-oxoadipate into 
L-2-aminoadipate is proposed in M. barkeri and L-2-aminodipate is transported into S. cattleya.
Three tentacular hyperacs are used in this case. One of the reactions is N-(5-amino-5-carboxypentanoyl)- 
L-cysteinyl-D-valine synthase that converts L-2-aminoadipate, L-valine and L-cysteine into δ-(L-2-aminoadipyl)- 
L-cysteinyl-D-valine, which is the starting point for the production of penicillin and cephalosporin C. All metab-
olites previously mentioned can be produced from pyruvate. The requirements to produce the three substrates of 
N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase using a solution of minimum weight therefore 
force to go back into the bacterium producing both amino-acids (L-valine and L-cysteine), in this example S. 
cattleya. The two other tentacular hyperarcs correspond to the reactions for citrate synthase (converts acetyl-
CoA, H20 and oxaloacetate into citrate and CoA) and AcetylCoA:2-oxoglutarate C-acetyltransferase (transforms 
2-oxoglutarate and AcetylCoA into Homocitrate ((R)-2-hydroxybutane-1,2,4 tricarboxylate).
Industrial biotechnology: Production of 1,3-propanediol and methane. The compound 
1,3-propanediol (PDO) is of high interest in biotechnology since it is used as a building block in polymers23. 
Bizukojc et al.10 reported that the co-culture of the 1,3-propanediol producer Clostridium butyricum with a 
Figure 2. Representation of two solutions of minimum weights. The circles are compounds. Black hyperarcs 
are endogenous reactions, that is reactions already present in the organisms forming the consortium, while 
purple-dashed hyperarcs are the reactions that were inserted. Green arcs represent the transport of pyruvate 
from Streptomyces cattleya to Methanosarcina barkeri and of 2-oxoadipate from M. barkeri to S. cattleya. The 
widths of the arcs are proportional to the assigned weights. Grey-dashed arcs represent an alternative path of 
endogenous reactions in the upper part of glycolysis. Hence, the second solution uses this path instead of the 
one just below to link β-D-glucose to D-glyceraldehyde 3-phosphate.
www.nature.com/scientificreports/
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methanogenic Archaea, namely Methanosarcina mazei, could lead to a better yield of production. Indeed, in 
C. butyricum, production of PDO leads to the production of acetate as well as of a side-compound, the latter then 
participating in the production in M. mazei of methane, which is the main molecule in the composition of biogas.
In this example, another PDO producer and Enterobacteria glycerol scavenger, namely Klebsiella pneumoniae, 
is associated with Methanosarcina mazei to produce 1,3-propanediol and methane. Both organisms have the 
capacity to produce the target compounds. Hence, no reference organisms were used. The weights were first set 
as in the previous section (i.e. wworker = 1, wother = 100, wtransition = 100). The only authorised source was glycerol. 
Indeed, glycerol is a by-product of biodiesel biodiesel. It therefore is a substrate of choice for biotechnological 
processes24. In this case, we have two targets: 1,3-propanediol and methane.
We obtain six solutions with the same weight of 110 (1 transition and 10 endogenous reactions). In K. pneumoniae, 
there are two ways of reaching glycerone phosphate from glycerol. Moreover, two different reactions are possible 
to transform pyruvate into acetyl-CoA, one of them forming also formate. Finally, in the solutions obtained, there 
is also the possibility to exchange pyruvate instead of Acetyl-CoA. This therefore leads to six solutions (four of 
them are represented in Fig. 3, the last two are available in the Supplementary Figure S6).
In this case, the community does not exchange acetate but acetyl-CoA or pyruvate. In eukaryotes, transporters 
of acetyl-CoA are known in several pluricellular organisms and also in yeast. However, no transporter of 
Figure 3. Solutions with uniform weights for the production of 1,3-propanediol from glycerol in  
K. pneumoniae and M. mazei. Black hyperarcs are endogenous reactions and green arcs represent transports. 
Grey dashed hyperarcs represent alternative paths.
Figure 4. Solutions with reduced weight for acetate and formate to produce 1,3-propanediol from glycerol 
in K. pneumoniae and M. mazei. Black hyperarcs are endogenous reactions and green arcs represent transports, 
here acetate from K. pneumoniae to M. mazei. The grey dashed arcs represent the alternative solution.
www.nature.com/scientificreports/
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acetyl-CoA has been detected in organisms close to the ones used in our case. Moreover, a pool of acetyl-CoA 
is essential to K. pneumoniae. Indeed, Jung et al.25 reported that a mutant with a reduced pool of acetyl-CoA 
showed growth retardation and redox imbalance. Therefore, it is not clear whether K. pneumoniae has an 
advantage in sharing acetyl-CoA or pyruvate (which is a substrate for the reactions producing acetyl-CoA). 
However, as stated previously, the production of 1,3-propanediol is associated with the synthesis of acetate and 
formate. Those by-products are inhibiting for K. pneumoniae and can reduce both its growth and the produc-
tion of 1,3-propanediol25,26. Finally, K. pneumoniae possesses a citrate/acetate exchanger27 which is CitW, and 
Methanosarcina spp. can grow on acetate although other substrates might be preferred. This indicates the possibil-
ity of an exchange of acetate between the two organisms since transport is possible in both species. We therefore 
decided to diminish the weight of the transport of those organic acids to wtransition = 50.
Two minimum solutions were obtained with a weight of 61 (the acetate transport with wtransition = 50 and 11 
endogenous reactions). They are presented in Fig. 4.
We can observe that this solution is really close to the previous one. Here, pyruvate is used to produce acetate 
(pyruvate:ubiquinone oxidoreductase) which is then exchanged from K. pneumoniae to M. mazei. The resulting 
pathway is in agreement with the one described by Sabra et al.5.
Discussion
The method introduced in this paper allows to infer topological sub-networks to produce target compounds 
using one or several microorganisms forming a consortium. Ensuring that a component will be produced as 
much as it will be consumed according to stoichiometric coefficients leads to a more complex problem. Since we 
do not use such coefficients, a conservative hypothesis was adopted. This induces the exclusion of some cycles 
where a substrate used in a reaction is immediately formed again (such phenomenon appears for example in the 
phosphotransferase system in E. coli). Without stoichiometric coefficients, we cannot guarantee that the interme-
diate substrates of the cycles will be all regenerated by a solution. Prohibiting those cycles allows us to ensure that 
all solutions are feasible by themselves, meaning that all intermediates are at least as much produced as they are 
consumed (regardless of the remaining of the network).
Once a solution is obtained several points must be verified.
In the first example, only two of the four bacteria were selected to produce the two compounds of interest, 
showing the ability of our algorithm MultiPus to not only identify the less costly solution, but also to select the 
best consortium among a larger set of microorganisms given as input.
In this synthetic bacterial consortium defined by Streptomyces cattleya and Methanosarcina barkeri, pyruvate 
and either 2-oxoadipate or L-2-aminoadipate are exchanged between the two prokaryotes. The organisms there-
fore need to be able to export and uptake the three compounds. It was shown that Methanosarcina barkeri–the 
model species of the genus Methanosarcina whose properties are shared by most of the others28–grows on pyru-
vate, the uptake being done by passive diffusion29.
Moreover, Streptomyces coelicolor is able to transport monocarboxylates such as pyruvate by secondary carri-
ers and active transporters30. Although pyruvate transporters have not yet been shown to exist in S. cattleya, it is 
probable that the transport of pyruvate is nevertheless possible since it happens in a closely related organism (i.e. 
S. coelicolor)30.
As concerns the second exchange, mitochondrial transporters for oxodicarboxylic acids (oxodicarboxylate 
carrier proteins (ODCs)) such as 2-oxoadipate and 2-oxoglutarate were reported in yeast (Saccharomyces cerevi-
siae) and in human31,32. Both human and yeast ODCs catalyse the transport of 2-oxoadipate and 2-oxoglutarate by 
a counter-exchange mechanism. Moreover, L-2-aminoadipate is also transported by the human ODC31. However, 
no homologous genes were found in Archaea and Actinobacteria (using a Blast analysis), neither did we find any 
information about the presence of such transporters in Methanosarcina or Streptomyces. Further experiments will 
therefore be needed to determine whether the two species constituting the microbial consortium do possess the 
ability to uptake and export 2-oxoadipate. Moreover, if it is confirmed that these two bacterial strains indeed lack 
this ability, an insertion of ODCs might still be possible, similarly to what was performed in Escherichia coli using 
human ODCs31.
Although the production of two beta-lactam antibiotics destroys the walls of positive Gram bacteria, 
Streptomyces is well-known for possessing a gene cluster which orchestrates antibiotic biosynthesis. Such cluster 
consists of resistance, transport and regulatory genes physically linked and coordinately regulated with genes 
encoding biosynthetic enzymes33. Among such species, Streptomyces clavuligerus produces several beta-lactam 
compounds, such as cephamycin C, clavulanic acid (an inhibitor of several beta-lactamases able to inactivate pen-
icillins20) and other structurally related clavams34. Moreover, thienamycin, a carbapenem compound belonging 
to a class of beta-lactam antibiotics, is produced by S. cattleya. This metabolite employs a similar mode of action 
as penicillins through disrupting the cell wall synthesis (peptidoglycan biosynthesis) of various Gram-positive 
and Gram-negative bacteria. It further presents a resistance to bacterial beta-lactamases enzymes20,35. Therefore, 
S. cattleya could produce the two beta-lactam antibiotics without affecting its bacterial growth.
One must however call attention here to the fact that cultivating an aerobiose Actinobacteria and an anaerobi-
ose Archaea in a same culture may be difficult. On one hand, several anaerobic-aerobic co-cultures have already 
been reported36. Indeed, because of the low solubility and diffusibility of oxygen in water, anaerobic micro-niches 
can be created and maintained in an aerobic environment36. On the other hand, we have here two mesophilic 
species: Streptomyces sp. (with a temperature growth interval between 25 °C and 35 °C) and Methanosarcina sp. 
(with an optimum of growth around 37 °C)37. In this context, the synthetic bacterial consortium will be able to 
grow together without major difficulties.
At their bacterial growth temperature (between 25 °C and 37 °C), we exclude a possible temperature-dependent 
biosynthetic pathway of antibiotic compounds as already reported for actinorhodin38. Indeed, the expression of 
the actinorhodin gene cluster was showed to be impossible at high temperatures (45 °C) and instead realised at 
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30 °C and at 37 °C, suggesting that it could thus depend on the temperature38. Under such conditions, the peni-
cillin and cephalosporin C gene cluster should therefore be heterologously expressed by the consortium which 
should be able to produce the two well-known beta-lactam antibiotics.
In the second example, we retrieved a possible network for the joint production of 1,3-propanediol and meth-
ane. In Jung et al.25, attempts to reduce the production of by-products such as acetate through gene deletion led 
to a growth defect in K. pneumoniae. In those experiments, the yield of 2,3-butanediol (BDO) is improved by 
deletion of pflB, possibly because of the accumulation of pyruvate, a precursor of BDO. Indeed, pflB with ldhA 
encodes the pyruvate formate-lyase enzyme. Nevertheless in our case, pyruvate is not a precursor of PDO, hence 
the deletion of the same gene (pflB) would have a negative impact since the growth of the cells would be impaired 
by the redox imbalance created. Hence the possibility of the association with an acetogenic Archaea is of great 
interest to regulate acetate production.
In Bizukojc et al.10, an in silico simulation of the co-culture of another propanediol producer, namely 
Clostridium butyricum, with M. mazei showed an improvement in the growth of C. butyricum due to the con-
sumption of acetate by M. mazei. Such consumption alleviates the inhibition of acetate. A similar effect should be 
expected for Klebsiella pneumoniae. The lighter weight assigned to the exchange of acetate allowed us to retrieve 
a feasible solution. Although acetate can be utilised almost completely by M. mazei for its growth, it is necessary 
to have methanol (present in raw glycerol obtained from biodiesel plant) in the medium to produce methane. 
However, even if the production of methane is low, the association of the two organisms will decrease the concen-
tration of extracellular acetate, which is toxic for K. pneumoniae, hence increasing the yield of PDO. Co-cultures 
of Clostridium sp. associated to methanogenes such as Methanosarcina sp. CHTI55 have been described in the 
literature, showing acetate utilisation by methanogene organisms39. The use of an Enterobacteria, Klebsiella pneu-
moniae, as the propanediol producer in co-culture with methanogenes has been less described. Hence, more 
extensive tests on the feasibility using classical optimisation techniques are needed, even though the process and 
apparatus for such associations have been patented40.
As shown in this second application, we can assign a non uniform weight to the exchange of compounds 
between organisms, the insertion of exogenous reactions or the use of internal reactions. Using a biological a 
priori to tune the weights assigned to each reaction is helpful to obtain a realistic solution. Indeed, the weight of 
an inserted reaction can be set more precisely by taking into account, for example, gene-reaction associations. 
Reactions catalysed by protein complexes require the insertion of several genes, hence may be harder to handle 
than those associated to single genes. Using the AND/OR relations available in the SBML models, insertion 
weights may thus be adapted to reflect those difficulties. Moreover, if information about the inserted organisms 
is available, more complex weights can be computed, taking into account enzyme promiscuity, catalytic per-
formance, gene compatibility41, but also for example the toxicity of side-products or even a known difficulty of 
enzyme incorporation. The exchange weights are harder to evaluate, however information about transporters 
(active or passive) for export and uptake may be taken into account to tune the exchange reactions. For example, 
a passive transporter is costless, molecules move across the membrane without energy input; on the contrary, an 
active transporter such as an ATP-powered pump will be costly since it requires the hydrolysis of ATP into ADP. 
Attributing a relative weight inside each category as briefly described above may be straightforward. What may be 
more difficult is to decide on how to balance such weights across the three categories. This may require some trial 
and error, and be dependent on the in silico experiment that is considered.
Conclusion
We proposed a new topological method, called MultiPus, to select possible microbial consortia for the production 
of compounds of interest.
With MultiPus, any situation of both exogenous and endogenous compounds might be considered, as well as 
larger initial consortia whose final composition in terms of species is then optimised by the method. Finally, by 
setting the sources required, one can test the possibility of using low-cost substrates for the production of high 
value chemicals.
As a post-processing step, classical methods of flux balance analysis (using the inferred topological network) 
can be employed to predict product yield42–44. Gene over-expression and knock-out can moreover be explored in 
order to guarantee both growth and production of the compound(s) of interest, but also interaction among the 
species present in the consortium45,46.
Indeed, the species that are part of the consortium may not have the same growth rate, hence may not reach an 
equilibrium in terms of composition when all organisms are present. Stable growth and equilibrium in biomass of 
the community which is being considered is of importance, and stoichiometric models could be used to predict 
such equilibrium11,47. If balance cannot be reached, it is necessary to create a beneficial interaction among the 
organisms involved (mutualism or syntrophy) to guarantee the success of the synthetic community48. If needed, 
mutualism can be enforced by genetic engineering, for example by creating auxotrophic strains; this will force a 
cross-feeding between organisms, regulating the growth of the species composing the co-culture49,50.
This first model allows to infer topologically possible insertions for heterologous expression and the usage 
of a mixed culture for the production of exogenous and/or endogenous target compounds. Moreover, MultiPus 
may thus enable to establish which co-cultures could be interesting to use in order to avoid the inhibition of 
co-products (e.g. 1,3-propanediol). It is a good starting point, that should be associated in the future with more 
quantitative methods in order to guarantee maintenance and growth of the organisms in communities (for 
instance, taking into account account electron transport and/or red/ox balance).
The implementation of the algorithm is available at: http://multipus.gforge.inria.fr.
www.nature.com/scientificreports/
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